Neuropsychiatric symptoms (NPSs) are common in patients with Alzheimer's disease (AD)
and are associated with accelerated cognitive impairment and earlier deaths. This review …

Structural imaging based on magnetic resonance is an integral part of the clinical
assessment of patients with suspected Alzheimer dementia. Prospective data on the natural …

General cognitive function is a prominent and relatively stable human trait that is associated
with many important life outcomes. We combine cognitive and genetic data from the …

Suspected non-Alzheimer disease pathophysiology (SNAP) is a biomarker-based concept
that applies to individuals with normal levels of amyloid-β biomarkers in the brain, but in …

Dementia affects 47 million individuals worldwide, and assuming the status quo is projected
to rise to 150 million by 2050. Prevention of age-related cognitive impairment in older …

Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing,
longitudinal, multicenter study designed to develop clinical, imaging, genetic, and …

Alzheimer's disease (AD) patients show altered patterns of functional connectivity (FC) on
resting state functional magnetic resonance imaging (RSfMRI) scans. It is yet unclear which …

Functions of the Alzheimer's Disease Neuroimaging Initiative (ADNI) magnetic resonance
imaging (MRI) core fall into three categories:(1) those of the central MRI core laboratory at …

The Alzheimer's Disease Neuroimaging Initiative (ADNI) beginning in October 2004, is a 6-
year research project that studies changes of cognition, function, brain structure and …

Abstract Introduction Alzheimer's Disease Neuroimaging Initiative (ADNI) is now in its 10th
year. The primary objective of the magnetic resonance imaging (MRI) core of ADNI has been …